GUIDANCE® UTI

GUIDANCE® UTI

THE RIGHT UTI THERAPY
RIGHT FROM THE START.

Guidance UTI is the only diagnostic test for both pathogen identification and antibiotic sensitivity that’s backed by patented technology. It’s time to provide your patients with personalized therapy options that work the first time.

BYPASS CHALLENGES TO GET TO THE RIGHT UTI TREATMENT QUICKLY

Traditional urine culture can give false-negative results.

 

Guidance® UTI uses molecular technology to identify pathogens more accurately and quickly than urine culture. Average turnaround time is less than 48 hours.

Genotypic resistance does not always correlate with phenotypic resistance.

 

Guidance® UTI uses Pooled Antibiotic Susceptibility Testing™ (P-AST™), a patented phenotypic testing method, to ensure that antibiotic resistance results reflect the infection’s actual resistance.

Standard urine culture is not always accurate in identifying susceptibility in polymicrobial infections.

Guidance® UTI’s proprietary P-AST technology captures the effects of bacterial interactions for more reliable susceptibility results.

 

WE’RE HERE TO HELP YOU OVERCOME UNRESOLVED UTIs QUICKLY.

My Patient’s UTI story

A video series dedicated to Urologists and the topic of urinary tract infections

What does Guidance UTI test for?

In addition to the often-tested organisms Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae, and Staphylococcus aureus, we also test for an extremely comprehensive list of pathogens.

BACTERIAL/YEAST ORGANISMS:
  • Acinetobacter baumannii
  • Actinotignum schaalii
  • Aerococcus urinae
  • Alloscardovia omnicolens
  • Candida albicans
  • Candida auris
  • Candida glabrata
  • Candida parapsilosis
  • Citrobacter freundii
  • Citrobacter koseri
  • Corynebacterium riegelii
  • Enterococcus faecalis
  • Enterococcus faecium
  • Escherichia coli
  • Klebsiella oxytoca
  • Acinetobacter baumannii
  • Actinobaculum schaalii
  • Aerococcus urinae
  • Alloscardovia omnicolens
  • Candida albicans
  • Candida glabrata
  • Candida parapsilosis
  • Citrobacter freundii
  • Citrobacter koseri
  • Corynebacterium riegelii
  • Enterobacter aerogenes
  • Enterococcus faecalis
  • Escherichia coli
  • Klebsiella oxytoca
  • Klebsiella pneumoniae
  • Morganella morganii
  • Mycobacterium tuberculosis
  • Mycoplasma genitalium
  • Mycoplasma hominis
  • Pantoea agglomerans
  • Proteus mirabilis
  • Providencia stuartii
  • Pseudomonas aeruginosa
  • Serratia marcescens
  • Staphylococcus aureus
  • Streptococcus agalactiae
  • Streptococcus pyogenes
  • Ureaplasma urealyticum
BACTERIAL GROUPS:
  • Coagulase-neg. staphylococci*
  • Viridans group streptococci†
  • Enterobacter group‡
VIRAL PARTICLES:
  • BK virus
  • HHV-5 (CMV)
  • HHV-6
  • HHV-1, HHV-2 (HSV 1/2)
  • JC virus
  • Klebsiella pneumoniae
  • Morganella morganii
  • Mycobacterium tuberculosis
  • Mycoplasma hominis
  • Pantoea agglomerans
  • Proteus mirabilis
  • Providencia stuartii
  • Pseudomonas aeruginosa
  • Serratia marcescens
  • Staphylococcus aureus
  • Streptococcus agalactiae
  • Ureaplasma urealyticum
SEXUALLY TRANSMITTED ORGANISMS:
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Trichomonas vaginalis
KEY
  • Guidance® UTI
  • Add-on tests

*Coagulase-neg. staphylococci: Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus lugdunensis, Staphylococcus saprophyticus

Viridans group streptococci: Streptococcus anginosus,
Streptococcus oralis, Streptococcus pasteuranus

‡Enterobacter group: Klebsiella aerogenes (formally known as Enterobacter aerogenes), Enterobacter clocacae

How does Guidance UTI recommend treatment?

We leverage a dual assessment—genotype resistance and Pooled Antibiotic Susceptibility Testing (P-AST)—to uncover more effective, personalized therapy options.

Pooled Antibiotic Susceptibility Testing (P-AST) includes:
  • Ampicillin (PO/IV)
  • Ampicillin/Sulbactam (IV)
  • Amoxicillin/Clavulanate (PO)
  • Cefaclor (PO)
  • Cefazolin (IV)
  • Cefepime (IV)
  • Cefoxitin (IV)
  • Ceftazidime (IV)
  • Ceftriaxone (IM/IV)
  • Ciprofloxacin (PO/IV)
  • Ampicillin (PO/IV)
  • Ampicillin/Sulbactam (IV)
  • Amoxicillin/Clavulanate (PO)
  • Cefaclor (PO)
  • Cefazolin (IV)
  • Cefepime (IV)
  • Cefoxitin (IV)
  • Ceftazidime (IV)
  • Ceftriaxone (IM/IV)
  • Ciprofloxacin (PO/IV)
  • Fosfomycin (PO/IV)
  • Gentamicin (IM/IV)
  • Levofloxacin (PO)
  • Meropenem (IV)
  • Nitrofurantoin (PO)
  • Piperacillin/Tazobactam (IV)
  • Sulfamethoxazole/Trimethoprim (PO/IV)
  • Tetracycline (PO)
  • Vancomycin (IV)
Genotype antibiotic resistance genes include:
  • Ampicillin
  • Carbapenem
  • Extended Spectrum Beta-Lactamase
  • Methicillin
  • Quinolinone/Fluoroquinolone
  • Vancomycin
  • Fosfomycin (PO/IV)
  • Gentamicin (IM/IV)
  • Levofloxacin (PO)
  • Meropenem (IV)
  • Nitrofurantoin (PO)
  • Piperacillin/Tazobactam (IV)
  • Sulfamethoxazole/Trimethoprim (PO/IV)
  • Tetracycline (PO)
  • Vancomycin (IV)
KEY
  • Guidance® UTI

WHAT IS THE TESTING METHODOLOGY FOR GUIDANCE UTI? 

Pathnostics’ GUIDANCE UTI Test utilizes PCR amplification for the targeted detection of agents. Pathogens are reported in ranges of organism(s) per milliliter of urine.

DIAGNOSE THE PROBLEM AT THE SOURCE.

Guidance UTI leverages molecular technology to detect more pathogens than traditional culture methods with a high degree of sensitivity, resulting in a more accurate diagnosis.

UNDERSTAND HOW TO ACCURATELY TREAT UTIs.

In populations 65 and older, the rate of polymicrobial infections could be as high as 39%.2 In these infections, bacterial species interact to either increase or decrease resistance against antibiotics. 3–7

To determine if pathogens have antibiotic resistance, some clinicians rely on the presence or absence of resistance genes (i.e., genotype testing). However, genotyping only reveals the genetic potential to develop resistance and does not determine what treatment will be effective against the pool of organisms.

Only Guidance UTI goes beyond genotype resistance testing by also including Pooled Antibiotic Susceptibility Testing (P-AST) to determine which treatment will be most effective against the pool of organisms as they grow and interact in the presence of antibiotics.

TAKE THE FAST TRACK TO EFFECTIVE THERAPY.

Traditional culture methods take up to three days or more to return results, requiring physicians to treat UTIs empirically while they wait. This can lead to overprescribing and antibiotic resistance. Guidance UTI delivers results in as quickly as 48 hours, enabling physicians to dispense precise, personalized treatment the first time, which ultimately advances patient care and antibiotic stewardship initiatives.

WORKFLOW TURNAROUND TIME

THE COMPLETE PATIENT PICTURE AT A GLANCE.

The Guidance UTI report displays personalized therapy options to help speed the road to recovery.

GET GUIDANCE UTI NOW

Ready to provide your patients with personalized therapy options that work the first time?